We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Platelet Membrane-Coated Nanoparticles Kill Circulating Tumor Cells and Prevent Metastasis in Breast Cancer Model

By LabMedica International staff writers
Posted on 25 Nov 2015
Print article
Silica nanoparticles functionalized with activated platelet membranes along with surface conjugation of the tumor-specific apoptosis-inducing ligand cytokine TRAIL were shown to facilitate the destruction of circulating tumor cells (CTCs) and prevent the spread of the disease in a mouse breast cancer metastasis model.

Investigators at Cornell University (Ithaca, NY, USA) had shown in previous studies that (CTCs) became part of a "microenvironment" when they became physically associated with activated platelets and fibrin while being transported in the bloodstream.

To attack the tumor cells within this microenvironment, the investigators prepared synthetic silica nanoparticles coated with proteins from activated platelet membranes. Molecules of the cytokine TRAIL (tumor necrosis factor related apoptosis-inducing ligand) were attached to the surface of the particles.

TRAIL is a cytokine that is produced and secreted by most normal tissue cells. It causes apoptosis primarily in tumor cells by binding to certain death receptors. Since the mid-1990s it has been used as the basis for several anti-cancer drugs, but had not been found to have any significant survival benefit.

The investigators reported in the October 21, 2015, online edition of the journal Biomaterials that their synthetic nanoparticles attached to "natural killer cells" in the blood which then became incorporated into CTC-associated micro-thrombi in blood vessels within the lungs. The ramped-up killer cells acted to dramatically decrease lung metastases in a mouse breast cancer metastasis model.

"In our research, we use nanoparticles— the liposomes we have created with TRAIL protein—and attach them to natural killer cells, to create what we call "super natural killer cells" and then these completely eliminate lymph node metastases in mice," said senior author Dr. Michael R. King, professor of biomedical engineering at Cornell University. "So, now we have technology to eliminate bloodstream metastasis—our previous work—and also lymph node metastases."

Related Links:

Cornell University



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.